Raltegravir is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of HIV-1 infection in combination with other ARV agents in ART-experienced pts with evidence of HIV replication despite ongoing ART.
- Treatment of HIV-1 infection in combination with other ARV agents in ART-naive pts.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Substitution for other ARV agents due to drug toxicity or intolerance in pts on suppressive regimen (limited data)
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: July 11, 2014
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Raltegravir
ID - 540471
A1 - Pham,Paul,Pharm.D. BCPS
AU - Hsu,Alice,Pharm.D.
AU - ,,
Y1 - 2014/07/11/
PB - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540471/all/Raltegravir
ER -